(ZWS) Zurn Elkay Water Solutions - Overview
Stock: Dispensers, Filtration, Valves, Sinks, Fixtures
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.93% |
| Yield on Cost 5y | 2.55% |
| Yield CAGR 5y | 6.99% |
| Payout Consistency | 70.0% |
| Payout Ratio | 34.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.7% |
| Relative Tail Risk | -6.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.10 |
| Alpha | 25.60 |
| Character TTM | |
|---|---|
| Beta | 0.881 |
| Beta Downside | 0.977 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.18% |
| CAGR/Max DD | 1.10 |
Description: ZWS Zurn Elkay Water Solutions January 09, 2026
Zurn Elkay Water Solutions Corp. (NYSE: ZWS) designs, procures, manufactures and markets a broad portfolio of water-management products-including filtered drinking stations, backflow preventers, pressure-reducing valves, and commercial-grade sinks-under the Elkay, Halsey Taylor, Zurn, Wilkins, Green Turtle, AquaSense, and related brands.
The company serves institutional, commercial, water-works, and residential customers across the United States, Canada and select international markets, reaching end-users through independent reps, plumbing wholesalers and specialty distributors in sectors such as food-service, industrial, janitorial and site-work.
Originally founded in 1891 and headquartered in Milwaukee, Wisconsin, the firm rebranded from Zurn Water Solutions to Zurn Elkay Water Solutions in July 2022 to reflect the integration of the Elkay acquisition.
According to its FY 2023 Form 10-K, ZWS generated roughly $1.1 billion in revenue with an adjusted EBITDA margin near 12 %, and its backflow-preventer line contributed about 15 % of total sales-a metric that tracks closely with municipal infrastructure spending cycles. The U.S. water-infrastructure pipeline is projected to exceed $1 trillion over the next decade, providing a secular demand tailwind for water-efficiency and safety products. Additionally, tighter building-code water-conservation standards (e.g., LEED v4.1 and state-level low-flow mandates) are accelerating adoption of ZWS’s EcoVantage and Zurn One fixture lines.
For a deeper, data-driven look at how ZWS’s valuation stacks up against its peers, you might explore the analytics on ValueRay to see the latest forward-looking cash-flow scenarios.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 192.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.77 > 1.0 |
| NWC/Revenue: 30.88% < 20% (prev 30.65%; Δ 0.23% < -1%) |
| CFO/TA 0.12 > 3% & CFO 318.4m > Net Income 192.3m |
| Net Debt (338.2m) to EBITDA (364.2m): 0.93 < 3 |
| Current Ratio: 2.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (170.3m) vs 12m ago -1.59% < -2% |
| Gross Margin: 44.02% > 18% (prev 0.45%; Δ 4356 % > 0.5%) |
| Asset Turnover: 61.59% > 50% (prev 57.40%; Δ 4.19% > 0%) |
| Interest Coverage Ratio: 9.27 > 6 (EBITDA TTM 364.2m / Interest Expense TTM 29.6m) |
Altman Z'' -0.64
| A: 0.19 (Total Current Assets 800.7m - Total Current Liabilities 288.2m) / Total Assets 2.68b |
| B: -0.43 (Retained Earnings -1.15b / Total Assets 2.68b) |
| C: 0.10 (EBIT TTM 274.5m / Avg Total Assets 2.69b) |
| D: -1.12 (Book Value of Equity -1.23b / Total Liabilities 1.09b) |
| Altman-Z'' Score: -0.64 = B |
Beneish M -3.10
| DSRI: 0.90 (Receivables 238.1m/247.4m, Revenue 1.66b/1.55b) |
| GMI: 1.03 (GM 44.02% / 45.20%) |
| AQI: 0.97 (AQ_t 0.64 / AQ_t-1 0.66) |
| SGI: 1.07 (Revenue 1.66b / 1.55b) |
| TATA: -0.05 (NI 192.3m - CFO 318.4m) / TA 2.68b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of ZWS shares?
Over the past week, the price has changed by +14.47%, over one month by +13.90%, over three months by +11.08% and over the past year by +39.10%.
Is ZWS a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ZWS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51.2 | -3% |
| Analysts Target Price | 51.2 | -3% |
| ValueRay Target Price | 66.2 | 25.4% |
ZWS Fundamental Data Overview February 03, 2026
P/E Forward = 26.3158
P/S = 4.6558
P/B = 4.8917
P/EG = 1.7522
Revenue TTM = 1.66b USD
EBIT TTM = 274.5m USD
EBITDA TTM = 364.2m USD
Long Term Debt = 495.5m USD (from longTermDebt, last quarter)
Short Term Debt = 15.4m USD (from shortTermDebt, last quarter)
Debt = 598.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 338.2m USD (from netDebt column, last quarter)
Enterprise Value = 8.06b USD (7.73b + Debt 598.3m - CCE 260.1m)
Interest Coverage Ratio = 9.27 (Ebit TTM 274.5m / Interest Expense TTM 29.6m)
EV/FCF = 27.94x (Enterprise Value 8.06b / FCF TTM 288.6m)
FCF Yield = 3.58% (FCF TTM 288.6m / Enterprise Value 8.06b)
FCF Margin = 17.39% (FCF TTM 288.6m / Revenue TTM 1.66b)
Net Margin = 11.59% (Net Income TTM 192.3m / Revenue TTM 1.66b)
Gross Margin = 44.02% ((Revenue TTM 1.66b - Cost of Revenue TTM 929.0m) / Revenue TTM)
Gross Margin QoQ = 44.07% (prev 45.51%)
Tobins Q-Ratio = 3.00 (Enterprise Value 8.06b / Total Assets 2.68b)
Interest Expense / Debt = 1.19% (Interest Expense 7.10m / Debt 598.3m)
Taxrate = 24.65% (19.5m / 79.1m)
NOPAT = 206.8m (EBIT 274.5m * (1 - 24.65%))
Current Ratio = 2.78 (Total Current Assets 800.7m / Total Current Liabilities 288.2m)
Debt / Equity = 0.38 (Debt 598.3m / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 0.93 (Net Debt 338.2m / EBITDA 364.2m)
Debt / FCF = 1.17 (Net Debt 338.2m / FCF TTM 288.6m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.14% (Net Income 192.3m / Total Assets 2.68b)
RoE = 12.23% (Net Income TTM 192.3m / Total Stockholder Equity 1.57b)
RoCE = 13.27% (EBIT 274.5m / Capital Employed (Equity 1.57b + L.T.Debt 495.5m))
RoIC = 10.07% (NOPAT 206.8m / Invested Capital 2.05b)
WACC = 8.57% (E(7.73b)/V(8.32b) * Re(9.16%) + D(598.3m)/V(8.32b) * Rd(1.19%) * (1-Tc(0.25)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.60%
[DCF Debug] Terminal Value 77.52% ; FCFF base≈281.2m ; Y1≈310.1m ; Y5≈399.6m
Fair Price DCF = 35.07 (EV 6.21b - Net Debt 338.2m = Equity 5.87b / Shares 167.4m; r=8.57% [WACC]; 5y FCF grow 11.85% → 2.90% )
EPS Correlation: 16.29 | EPS CAGR: -44.79% | SUE: -4.0 | # QB: 0
Revenue Correlation: 76.38 | Revenue CAGR: 19.66% | SUE: 2.10 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.36 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=1.66 | Chg30d=+0.006 | Revisions Net=+2 | Growth EPS=+10.1% | Growth Revenue=+5.5%